Skip to main content
. 2020 Oct 27;43(2):601–612. doi: 10.1002/hed.26515

TABLE 1.

Patient characteristics

No. of patients No. of patients (%)
Tumor site
Oral cavity 429 28%
Oropharynx a 624 41%
Hypopharynx 170 11%
Larynx 314 20%
Clinical stage (TNM7)
III 393 26%
IVA 1001 65%
IVB 143 9%
Gender
Male 1097 71%
Female 440 29%
Age at diagnosis Median 62 years (range 20‐93)
Median follow‐up 50.5 months (95% CI 47.9‐54.2)
a

377 were p16 positive (60%) and 247 (40%) were p16 negative.